|
|
Volumn 14, Issue 5, 2000, Pages 941-943
|
|
Arsenic trioxide (As2O3) gradually downregulates tissue factor expression without affecting thrombomodulin expression in acute promyelocytic leukemia cells [1]
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARSENIC TRIOXIDE;
D DIMER;
FIBRIN DEGRADATION PRODUCT;
FIBRINOGEN;
HYBRID PROTEIN;
MESSENGER RNA;
PROTEIN C;
RETINOIC ACID;
THROMBIN;
THROMBOMODULIN;
THROMBOPLASTIN;
ANTINEOPLASTIC AGENT;
ORGANOARSENIC DERIVATIVE;
OXIDE;
ACUTE MYELOBLASTIC LEUKEMIA;
APOPTOSIS;
BLOOD CLOTTING DISORDER;
CELL DIFFERENTIATION;
CELL GRANULE;
CELL NUCLEUS;
CHROMATIN CONDENSATION;
CONTROLLED STUDY;
CYTOPLASM;
DISSEMINATED INTRAVASCULAR CLOTTING;
DOWN REGULATION;
FIBRINOLYSIS;
HUMAN;
HUMAN CELL;
LETTER;
LEUKEMIA CELL;
PRIORITY JOURNAL;
CELL CULTURE;
DRUG EFFECT;
GENE EXPRESSION REGULATION;
GENETIC TRANSCRIPTION;
GENETICS;
PROMYELOCYTIC LEUKEMIA;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
ANTINEOPLASTIC AGENTS;
ARSENICALS;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
OXIDES;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
THROMBOMODULIN;
THROMBOPLASTIN;
TRANSCRIPTION, GENETIC;
TRETINOIN;
TUMOR CELLS, CULTURED;
|
|
EID: 0033625035
PISSN: 08876924
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.leu.2401755 Document Type: Letter |
|
Times cited : (6)
|
|
References (6)
|
